---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-128289"
form_type: "8-K"
ticker: "TAOX"
cik: "0001571934"
company_name: "TAO Synergies Inc."
filed_at: "2023-12-21T23:59:59+00:00"
generated_at: "2026-06-07T09:04:25.231156+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Synaptogenix stockholders approve reverse stock split authorization and tripling of equity plan shares

## Summary
- Stockholders authorized reverse stock split at ratio between 1:8 and 1:25, at Board's discretion.
- Amendment to 2020 Equity Incentive Plan approved, increasing authorized shares from 1.375M to 4.375M.
- Directors Alan Tuchman and Daniel L. Alkon elected with ~4.5M and ~4.7M for votes respectively.
- Ratification of Marcum LLP as auditor for FY2023 approved with ~10.66M for votes.

## SEC filing metadata
- accession: 0001104659-23-128289
- form_type: 8-K
- ticker: TAOX
- cik: 0001571934
- company_name: TAO Synergies Inc.
- filed_at: 2023-12-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/tm2333484d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-128289
- JSON: https://secwatch.observer/filing/0001104659-23-128289.json
- Plain text: https://secwatch.observer/filing/0001104659-23-128289.txt

## Key facts
- Shareholder Votes
  TAO Synergies Inc. shareholders approved Board Authorization to Effect a Reverse Stock Split.
  - Proposal: reverse split
  - Outcome: passed
  source text: Proposal 2 – Board Authorization to Effect a Reverse Stock Split Our stockholders voted to authorize our board of directors (the “Board”) to effect one reverse stock split of our outstanding shares of Common Stock, at a ratio between 1-for-8 and 1-for-25 (or any number in between), at such time, if any, as our Board shall determine, in its sole discretion. Shares Voted For Shares Voted Against Abstentions 8,661,349 3,093,253 188,441
  evidence_url: https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm
- Shareholder Votes
  TAO Synergies Inc. shareholders approved Election of two directors to serve until the 2026 annual meeting.
  - Proposal: director election
  - Outcome: passed
  source text: Proposal 1 - Election of Directors Our stockholders voted to elect two directors to hold office until the 2026 annual meeting of stockholders, and until their respective successors are elected and qualified, by the following votes: Nominee For Withheld Broker Non-Votes Alan Tuchman 4,505,521 1,451,157 5,986,368 Daniel L. Alkon 4,728,376 1,228,302 5,986,368
  evidence_url: https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm
- Shareholder Votes
  TAO Synergies Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm - Marcum LLP at the 2023-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-31
  source text: Proposal 4 - Ratification of Selection of Independent Registered Public Accounting Firm. The ratification of appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Shares Voted For Shares Voted Against Abstentions 10,660,952 994,599 287,495
  evidence_url: https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm
- Shareholder Votes
  TAO Synergies Inc. shareholders approved Approval of Amendment to the Synaptogenix, Inc. 2020 Equity Incentive Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Proposal 3 - Approval of Amendment to the Synaptogenix, Inc. 2020 Equity Incentive Plan Our stockholders voted to approve an amendment to our Plan to increase the total number of shares of Common Stock authorized for issuance thereunder from 1,375,000 shares of Common Stock to an aggregate of 4,375,000 shares of Common Stock by the following votes: Shares Voted For Shares Voted Against Abstentions Broker Non-Votes 3,356,208 2,324,244 276,226 5,986,368
  evidence_url: https://www.sec.gov/Archives/edgar/data/1571934/000110465923128289/0001104659-23-128289-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.